Mild to modrate acne vulgaris. Acne vulgaris
Conditions
Interventions
Intervention 1: Intervention group: combination of erythromycin 4 g and salicylic acid in 10 cc propylene glycol and alcohol 70 degrees to the volume of the overall 100 cc
will apply to the face with
Treatment - Drugs
Intervention group: combination of erythromycin 4 g and salicylic acid in 10 cc propylene glycol and alcohol 70 degrees to the volume of the overall 100 cc
will apply to the face with cotton applica
Control group:
combination of erythromycin 4 g in 10 cc propylene glycol and alcohol 70 degrees to the volume of the overall 100 cc
will be apply to the face with cotton applicator twice aday for 3
Sponsors
Deputy of Tabriz University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
11 Years to 30 Years
Inclusion criteria
Inclusion criteria: Exclusion criteria:patients who are using topical or systemic steroids ; patients who are using contraceptive pills (anti-androgen); patients who are used topical or oral anti-acne medications, during the previous month, even include natural and UV light and Herbal and traditional acne treatments; if there are other face dermatosis and other systemic acne accelerator diseases such as Cushing's syndrome, PCO,adrenal hyperplasia, acquired and innate immun deficiency, steroid acne and acneiform lesions and ....; patient's dissatisfaction ;if there are more than 20 inflammatory lesions (papules and pustules) and three nodules or cysts on one side of the face ; patients with acne excoree ;age under 11 y/o andover 30 y/o ;if there is an inflammatory disease,except acne, on the face such as contact dermatitis, allergic or seborrheic dermatitis and... Inclusion criteria:patients with mild to moderate acne in age range 11-30 years old ; patients who have maximum 20 inflammatory lesions (papules &pustule) on one side of the face and have not more than three nodules or cysts on the same side of the face; lack of other face dermatosis such as contact dermatitis, allergic or seborrheic dermatitis and ...; having patient's satisfaction ; lack of other systemic acne accelerator diseases such as Cushing's syndrome, PCO, adrenal hyperplasia, acquired and innate immun deficiency, steroid acne and acneiform lesions and.... ; patients who are not used of oral or topical anti-acne medications, during the previous month, even include natural and UV light, herbal and traditional acne treatments.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acne severity index. Timepoint: Every15 days. Method of measurement: History, physical examination, counting and statistical evaluation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Age. Timepoint: Every 15 days. Method of measurement: History.;Gender. Timepoint: Every 15 days. Method of measurement: History.;Comedon. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Papule. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Pustule. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Total numbers of lesions. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Patient's satisfaction. Timepoint: Every 15 days. Method of measurement: History.;Side efect of treatment. Timepoint: Every 15 days. Method of measurement: History and physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarideh Golfroushan
Deputy of Tabriz University of Medical Sciences and Health Services
Outcome results
None listed